A rare case of acute myocardial infarction during extraction of a septally placed implantable cardioverter-defibrillator lead

A rare case of acute myocardial infarction during extraction of a septally placed implantable cardioverter-defibrillator lead

Bibliographic Details
Main Authors:	Eric Wierda, MD, LLM, Astrid A. Hendriks, MD, Giovanni Amoroso, MD, PhD, Daniel Mol, Dirk J. van Doorn, MD, PhD, Muchtiar Khan, MD
Format:	Article
Language:	English
Published:	Elsevier 2018-03-01
Series:	HeartRhythm Case Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214027117301902

Similar Items

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator
by: Kazuya Mizukami, MD, PhD, et al.
Published: (2017-06-01)

Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
by: Anita Rahmawati, MD, et al.
Published: (2016-04-01)

Usefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: A single-center European experience
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2015-10-01)

The role of catheter ablation in the management of patients with implantable cardioverter defibrillators presenting with electrical storm
by: Stelios Paraskevaidis, MD, PhD, et al.
Published: (2017-01-01)

Successful management of wound dehiscence after implantation of a subcutaneous implantable cardioverter-defibrillator without device removal
by: Mitsuhiro Fukata, MD, PhD, et al.
Published: (2017-09-01)

Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum
by: Yusuke Kondo, M.D., Ph.D., et al.
Published: (2017-02-01)

Fibrous encapsulation of defibrillation electrode and elevated high-voltage impedance in patients with a subcutaneous implantable cardioverter-defibrillator
by: Jian-Ming Li, MD, PhD, FHRS, et al.
Published: (2020-03-01)

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillatorKey Findings
by: Yuji Ishida, MD, PhD, et al.
Published: (2020-04-01)

Molecular mechanisms of heart failure progression associated with implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias
by: Yukiomi Tsuji, MD, PhD, et al.
Published: (2014-08-01)

Spiritual Well-Being May Buffer Psychological Distress in Patients With Implantable Cardioverter Defibrillators
by: Elena Salmoirago-Blotcher MD, PhD, et al.
Published: (2012-10-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Successful implantable cardioverter-defibrillator implantation through a communicating branch of the persistent left superior vena cava
by: Vineet Kumar, MD, et al.
Published: (2015-10-01)

Soft Tissue and Skin Reinforcement with Acellular Dermal Matrix to Protect Implanted Cardioverters/Defibrillators and Pacemakers
by: Ross Rudolph, MD, et al.
Published: (2018-07-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator
by: Sing-Chien Yap, MD, PhD, et al.
Published: (2015-05-01)

The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot
by: Satoshi Kawada, MD, PhD, et al.
Published: (2021-05-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

First direct human evidence of a probable implantable cardioverter-defibrillator lead-related scar serving as a substrate for ventricular tachycardia
by: Pal Abraham, MD, et al.
Published: (2015-01-01)

Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome
by: Hirotaro Sugiyama, MD, et al.
Published: (2017-06-01)

Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation
by: Atsushi Suzuki, MD, et al.
Published: (2015-06-01)

Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators
by: Luca Santini, MD, PhD, et al.
Published: (2017-06-01)

Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential oversensing
by: Paola Berne, MD, et al.
Published: (2017-10-01)

Usefulness of a wearable cardioverter defibrillator combined with catheter ablation for ventricular tachyarrhythmia storms after a myocardial infarction: A case report
by: Yusuke Yoshikawa, MD, et al.
Published: (2015-08-01)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
by: Daisuke Ishigaki, M.D., et al.
Published: (2016-12-01)

Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction
by: Laura Jimenez-Juan, MD, et al.
Published: (2017-04-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
by: Mohammad-Ali Jazayeri, MD, et al.
Published: (2017-06-01)

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
by: Bruce L. Wilkoff, MD, FHRS, CCDS, et al.
Published: (2016-02-01)

Compromised Sexual Health Among Male Patients With Implantable Cardioverter Defibrillator: A Cross-Sectional Questionnaire Study
by: Pernille Palm, RN, PhD, et al.
Published: (2019-06-01)

Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular fibrillation
by: Blake E. Fleeman, MD, et al.
Published: (2017-01-01)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
by: Matthew F. Yuyun, MD, MPhil, PhD, et al.
Published: (2020-05-01)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
by: Ariel Vinas, MD, et al.
Published: (2021-02-01)

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Premature Acute Myocardial Infarction in a Young Patient With Sitosterolemia
by: Yoshihiro Yamada, MD, PhD, et al.
Published: (2021-08-01)

The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet
by: Mahmoud Assaad, MD, et al.
Published: (2016-01-01)

Undetected ventricular fibrillation in a single-chamber implantable cardioverter-defibrillator: When the far-field channel sees more than the intraventricular channel
by: Milena Kubickova, MD, et al.
Published: (2016-07-01)

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
by: Sajya M. Singh, BS, et al.
Published: (2021-08-01)

Lingular pneumonia obscured by implanted cardioverter-defibrillator: Lateral thinking
by: Laura Sewell, MD, et al.
Published: (2015-01-01)